FDA Inspection 1073015 — Margaret Dillon

Margaret Dillon — FEI 3014703112

The FDA completed an inspection of Margaret Dillon on Nov 2, 2018 in Chapel Hill, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 2, 2018
Fiscal Year
2019
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Chapel Hill, NC (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.